PubRank

M Alessiani

Author PubWeight™ 75.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Kidney transplantation under FK 506. JAMA 1990 7.45
2 The many faces of multivisceral transplantation. Surg Gynecol Obstet 1991 6.89
3 Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg 1990 5.01
4 Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications. Transplant Proc 1990 4.90
5 The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. Transplantation 1991 3.14
6 Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc 1991 2.59
7 A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc 1991 2.49
8 Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc 1991 2.26
9 One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults. Transplant Proc 1991 2.10
10 Conversion of liver allograft recipients from cyclosporine to FK506 immunosuppressive therapy--a clinicopathologic study of 96 patients. Transplantation 1992 1.45
11 Adverse effects associated with the use of FK 506. Transplant Proc 1991 1.41
12 Neurologic complications of FK 506. Transplant Proc 1991 1.34
13 Pharmacokinetics of FK 506 in transplant patients. Transplant Proc 1991 1.30
14 The spectrum of aspergillosis in liver transplant patients: comparison of FK 506 and cyclosporine immunosuppression. Transplant Proc 1991 1.05
15 Current status of FK 506 in liver transplantation. Transplant Proc 1991 1.04
16 Expressive dysphasia possibly related to FK506 in two liver transplant recipients. Transplantation 1990 1.04
17 Abdominal spilled stones: ultrasound findings. Abdom Imaging 2006 1.03
18 Which is the most suitable and effective route of administration for mesenchymal stem cell-based immunomodulation therapy in experimental kidney transplantation: endovenous or arterial? Transplant Proc 2010 1.02
19 FK 506 dosage in human organ transplantation. Transplant Proc 1990 0.99
20 Mesenchymal stem cells infusion prevents acute cellular rejection in rat kidney transplantation. Transplant Proc 2010 0.94
21 Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. Transplant Proc 1991 0.94
22 Comparative study of cyclosporine and FK 506 dosage requirements in adult and pediatric orthotopic liver transplant patients. Transplant Proc 1991 0.93
23 FK 506 versus cyclosporine in pediatric liver transplantation. Transplant Proc 1991 0.93
24 Irreversible intestinal failure, nutrition support, and small bowel transplantation. Nutrition 2001 0.90
25 New strategies in immunosuppression. Transplant Proc 2005 0.90
26 Factors influencing Islet of Langerhans graft function and monitoring. Clin Chim Acta 2001 0.89
27 A rare case of pancreatic lipoma. Hepatogastroenterology 1997 0.89
28 Intravenous, oral pharmacokinetics, and oral dosing of FK 506 in small bowel transplant patients. Transplant Proc 1992 0.87
29 Isolation and ex vivo expansion of bone marrow-derived porcine mesenchymal stromal cells: potential for application in an experimental model of solid organ transplantation in large animals. Transplant Proc 2010 0.86
30 Strategy of FK 506 therapy in liver transplant patients: effect of graft function. Transplant Proc 1991 0.83
31 Infectious complications after human small bowel transplantation. Transplant Proc 1992 0.82
32 The maltose absorption test does not predict allograft rejection of small bowel transplantation in FK 506 immunosuppressed pigs. Transplant Proc 1994 0.82
33 Serum cytokine levels after small bowel transplantation in pigs. Transplant Proc 1994 0.82
34 Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506. Transplant Proc 1991 0.82
35 Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. Transplant Proc 1991 0.81
36 Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation. Transplant Proc 1991 0.80
37 FK 506 used as rescue therapy for human liver allograft recipients. Transplant Proc 1991 0.80
38 Robotic-assisted laparoscopic donor nephrectomy with transvaginal extraction of the kidney. Am J Transplant 2010 0.79
39 Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection. Transplant Proc 1991 0.79
40 Elemental enteral nutrition preserves the mucosal barrier and improves the trophism of the villi after small bowel transplantation in piglets. Transplant Proc 2007 0.79
41 Platelet-Independent defect in hemostasis associated with sirolimus use. Transplant Proc 2004 0.79
42 Infections during a randomized trial comparing cyclosporine to FK 506 immunosuppression in liver transplantation. Transplant Proc 1992 0.79
43 Stimulatory effect of FK506 and erythromycin on pig intestinal motility. Transplant Proc 1996 0.78
44 Infections after liver transplantation: risk factors and prevention. Transplant Proc 1991 0.76
45 Overview of FK506 in transplantation. Clin Transpl 1990 0.76
46 Experimental small bowel transplantation from non-heart-beating donors: a large-animal study. Transplant Proc 2009 0.76
47 Prognostic value of skin histology in GVHD after intestinal transplantation. Eur J Pediatr Surg 2007 0.76
48 Immunomodulatory properties of porcine, bone marrow-derived multipotent mesenchymal stromal cells and comparison with their human counterpart. Cell Mol Biol (Noisy-le-grand) 2011 0.76
49 Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506. Transplant Proc 1991 0.75
50 Early infections in kidney transplant recipients under FK 506. Transplant Proc 1991 0.75
51 In vitro assessment of FK 506 immunosuppressive activity in transplant patients. Transplant Proc 1991 0.75
52 Acute hemolytic anemia in liver and bone marrow transplant patients under FK 506 therapy. Transplant Proc 1991 0.75
53 Nephrectomy as a component of systemic treatment for renal cell carcinoma patients. J Surg Oncol 1994 0.75
54 Bacterial translocation is enhanced in pig intestinal transplantation when the colon is included in the graft. Transplant Proc 1996 0.75
55 Prolonged survival with FK778 (malononitrilamide) monotherapy after small bowel transplantation: a large animal study. Transplant Proc 2007 0.75
56 Small bowel myoelectrical activity after transplantation in pigs: motility versus ACR score. Transplant Proc 1997 0.75
57 Skin biopsies predict acute graft-versus-host disease after small bowel transplantation in pigs. Acta Vet Hung 2007 0.75
58 Two-year follow-up of potential candidates for small bowel transplantation. Transplant Proc 1996 0.75
59 Reduced intestinal myoelectrical activity during rejection of small bowel allografts in pigs. Transplant Proc 1996 0.75
60 Potential small bowel transplant recipients in Italy. Italian National Register of Home Parenteral Nutrition. Transplant Proc 1994 0.75
61 Assessment of an LC-MS method for plasma quantification of the new immunosuppressant FK778 through comparison with HPLC-UV. Transplant Proc 2005 0.75
62 Differences in hemodynamic stability at reperfusion during intestinal transplantation with and without colon in pigs. Transplant Proc 1996 0.75
63 Morphology of acute rejection and observation of lymphoproliferative hyperplastic reaction in FK 506 treated pigs after small bowel transplantation. Transplant Proc 1994 0.75
64 Early outcome of different steroid-free regimens in small bowel transplantation: a large-animal study. Transplant Proc 2006 0.75
65 Interaction between FK 506 and diltiazem in an animal model. Transplant Proc 1996 0.75
66 [Hemodynamic changes in liver and multi-organ transplantation]. Minerva Chir 1993 0.75
67 Development of a model of combined bone marrow and small bowel transplantation in swine. Transplant Proc 1998 0.75
68 [Hemorrhage through Wirsung's duct]. Minerva Chir 1986 0.75
69 Infectious complications in experimental small bowel transplantation. Transplant Proc 1994 0.75
70 Pharmacokinetics of FK506 and mycophenolic acid in experimental and clinical intestinal transplantation. Transplant Proc 1997 0.75
71 FK778 does not impair intestinal allograft absorption in a preclinical model of total small bowel transplantation. Transplant Proc 2006 0.75
72 Tacrolimus and mycophenolate mofetil in pig small bowel transplantation: different protocols and their outcome. Transplant Proc 1997 0.75
73 [Experimental kidney transplantation: a comparison between different models]. Minerva Chir 2003 0.75
74 Pharmacokinetic profile of mycophenolic acid in piglets after small bowel transplantation. Transplant Proc 1996 0.75
75 Incidence of graft rejection in small bowel transplanted pigs after immunosuppression withdrawal. Transplant Proc 2006 0.75
76 Mycophenolic acid in combination with FK 506: a pharmacokinetic study in piglets after small-bowel transplantation. Transplant Proc 1997 0.75
77 Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients. Oncol Rep 2011 0.75
78 [Laparoscopic harvest of the jejunal free flap for cervical esophageal reconstruction]. Minerva Chir 2006 0.75
79 Monitoring of intestinal myoelectrical activity after isolated small bowel transplantation in FK 506 immunosuppressed pigs. Transplant Proc 1994 0.75
80 Hemodynamic changes during experimental small bowel transplantation. Transplant Proc 1994 0.75